Device Trial Radar · NCT02089607
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
Last checked: Nov 20, 2026Latest source record: Aug 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
760
Planned (sponsor's estimate)
Start
Mar 2014
Primary completion
Mar 2028
Study completion May 2032
Sponsor
- Lead sponsor
- Gustavo S OderichAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- William Cook Australia
- First posted
- Mar 18, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to gather safety and effectiveness of the Zenith t-Branch and customized physician-specified stent-graft with a combination of fenestrations and/or branches to repair aortic aneurysm.
Conditions
- Complex Abdominal Aortic Aneurysm
- Thoracoabdominal Aortic Aneurysm
- Aortic Arch Aneurysm
- Aortic Arch Dissection
Interventions
CAAA and TAAA ArmDevice
The Zenith Fenestrated-Branched System is a tubular graft made of polyester fabric sewn to stainless steel stents that keep the graft open. The graft will be inserted through arteries in the leg (called endovascular repair). This procedure uses catheters that go inside the blood vessel to place a stent graft above and below the aneurysm. The graft includes 1 to 5 small holes (fenestrations) or cuffs (side branches). One or more than one of the study devices including the Zenith® Fenestrated AAA Endovascular Graft, Zenith® t-Branch Endovascular Graft, Patient-Specific Thoracoabdominal Graft, Patient-Specific Distal Bifurcated Component, and Zenith® Branch Endovascular Graft-Iliac Bifurcation will be implanted. The arteries to the liver, intestine, and kidneys will have a stent (small tubular stainless steel structures) to help keep the arteries open and aligned with the fenestrations or branches.
Aortic Arch Aneurysm ArmDevice
The Zenith® Arch Branch Endovascular Graft includes the main aortic arch portion and one to three cuffs (side branches) that allow the graft to be located in the aortic arch. The number of cuffs is decided based on the anatomy of your aneurysm. The arteries in the aortic arch are the innominate artery (Zone 0), left common carotid artery (Zone 1) and the left subclavian artery (Zone 2). These arteries supply the right arm and right side of the brain, the left side of the brain and the left arm, respectively. The main aortic endovascular graft will be connected into the innominate artery, left common carotid artery and left subclavian artery using additional stents into the branch vessels.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of subjects who have died at 30 days post treatmentTime frame: 30 days post treatment
- Number of subjects who experience a Major Adverse Event at 30 days post treatmentTime frame: 30 days post treatment
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic
Rochester, Minnesota · Active not recruiting
Baylor College of Medicine
Houston, Texas · Recruiting
University of Texas Health Science Center at Houston
Houston, Texas · Active not recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.